These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1102 related articles for article (PubMed ID: 2807622)

  • 1. Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice.
    Favalli C; Mastino A; Jezzi T; Grelli S; Goldstein AL; Garaci E
    Int J Immunopharmacol; 1989; 11(5):443-50. PubMed ID: 2807622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between thymic hormones and other immunomodulatory agents.
    Mastino A; Favalli C; Grelli S; Garaci E
    Ann Ist Super Sanita; 1991; 27(1):51-6. PubMed ID: 1958028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of natural killer activity by thymosin alpha 1 and interferon.
    Favalli C; Jezzi T; Mastino A; Rinaldi-Garaci C; Riccardi C; Garaci E
    Cancer Immunol Immunother; 1985; 20(3):189-92. PubMed ID: 3851698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon alpha 2b decreases hepatic micrometastasis in a murine model of ocular melanoma by activation of intrinsic hepatic natural killer cells.
    Yang H; Dithmar S; Grossniklaus HE
    Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2056-64. PubMed ID: 15223777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment using thymosin alpha 1 and interferon after cyclophosphamide is able to cure Lewis lung carcinoma in mice.
    Garaci E; Mastino A; Pica F; Favalli C
    Cancer Immunol Immunother; 1990; 32(3):154-60. PubMed ID: 2126987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of in vivo administration of prostaglandins and interferon on natural killer activity and on B-16 melanoma growth in mice.
    Garaci E; Mastino A; Jezzi T; Riccardi C; Favalli C
    Cell Immunol; 1987 Apr; 106(1):43-52. PubMed ID: 3568147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice.
    Mastino A; Favalli C; Grelli S; Innocenti F; Garaci E
    Cell Immunol; 1991 Mar; 133(1):196-205. PubMed ID: 1991327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective activity of thymosin alpha 1 against tumor progression in immunosuppressed mice.
    Ishitsuka H; Umeda Y; Sakamoto A; Yagi Y
    Adv Exp Med Biol; 1983; 166():89-100. PubMed ID: 6650286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer activity in cloned cytotoxic T lymphocytes: regulation by interleukin 2, interferon, and specific antigen.
    Brooks CG; Holscher M; Urdal D
    J Immunol; 1985 Aug; 135(2):1145-52. PubMed ID: 2409140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymosin alpha 1 restores NK-cell activity and prevents tumor progression in mice immunosuppressed by cytostatics or X-rays.
    Umeda Y; Sakamoto A; Nakamura J; Ishitsuka H; Yagi Y
    Cancer Immunol Immunother; 1983; 15(2):78-83. PubMed ID: 6553515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of mouse natural killer (NK) cell activity: effect of interleukin-2 (IL-2) and interferon (IFN) on the in vivo development of natural killer cells from bone marrow (BM) progenitor cells.
    Riccardi C; Giampietri A; Migliorati G; Cannarile L; D'Adamio L; Herberman RB
    Int J Cancer; 1986 Oct; 38(4):553-62. PubMed ID: 2944847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined treatment with thymosin alpha 1 and interferon enhances NK activity in immunosuppressed tumor bearing mice.
    Pica F; Mastino A; Grelli S; Jezzi T; Favalli C
    J Chemother; 1989 Jul; 1(4 Suppl):1167-9. PubMed ID: 16312818
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic differences in the age-associated decrease in inducibility of natural killer cells by interferon-alpha/beta.
    Plett A; Murasko DM
    Mech Ageing Dev; 2000 Jan; 112(3):197-215. PubMed ID: 10687925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine strain variation in the natural killer cell and proliferative responses to the immunostimulatory compound 7-allyl-8-oxoguanosine: role of cytokines.
    Pope BL; Chourmouzis E; MacIntyre JP; Lee S; Goodman MG
    Cell Immunol; 1994 Dec; 159(2):194-210. PubMed ID: 7994754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-dependent suppression of melanoma metastases and natural killer cell activation by interferon.
    Ueda M; Mishima Y; Mojamdar M; Ichihashi M; Kita M; Kishida T
    Arch Dermatol Res; 1986; 278(4):329-34. PubMed ID: 3740943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-induced suppression of interferon-gamma production and enhancement of interleukin-10 production by natural killer (NK) cells: paralleled to CD4+ T cells.
    Wei H; Zheng X; Lou D; Zhang L; Zhang R; Sun R; Tian Z
    Mol Immunol; 2005 May; 42(9):1023-31. PubMed ID: 15829292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of natural killing activity by lymphoblastoid interferon in cancer patients.
    Koren HS; Brandt CP; Tso CY; Laszlo J
    J Biol Response Mod; 1983; 2(2):151-65. PubMed ID: 6644332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antitumor effect of human interferon-alpha A/D in mice (II). Activation of natural killer cells and suppression of metastasis].
    Yokoyama T; Yoshie O; Aso H; Ebina T; Ishida N
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):510-5. PubMed ID: 2988456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma.
    Markovic SN; Murasko DM
    Cancer Res; 1991 Feb; 51(4):1124-8. PubMed ID: 1705166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced immune response and antitumor immunity with combinations of biological response modifiers.
    Garaci E; Mastino A; Favalli C
    Bull N Y Acad Med; 1989 Jan; 65(1):111-9. PubMed ID: 2481523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.